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Abstract
Antidiabetic and antihyperlipidemic
effect of Hemidesmus indicus
Linn.R.root. (HIR) was investigated in
rats. Administration of HIR (40 mg/g
body weight/day) for four weeks
significantly decreased the serum
cholesterol, triglyceride, free fatty acids
and phospholipid. Four weeks
treatment of diabetic rats with HIR (40
mg/g body weight/day) showed
significant hypoglycemic effect.
Results of the present study show that
HIR has hypocholesterolemic and
antidiabetic effects.
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Introduction
Diabetes mellitus is characterized by
hyperglycemia together with
biochemical alterations of glucose and
lipid metabolism (1). Liver is an insulin
dependent tissue, which plays a vital
role in glucose and lipid homeostasis
and is severely affected during diabetes
(2). Liver participates in the uptake,
oxidation and metabolic conversion of
free fatty acids, synthesis of cholesterol,
phospholipids and triglycerides.
During diabetes a profound alteration
in the concentration and composition of
lipid. (3). Decreased glycolysis, impeded
glycogenesis and increased glucon
eogenesis are some of the changes of
glucose metabolism in the diabetic liver
(4). Many traditional plant treatments for
diabetes mellitus are used throughout
the world (5).  Few of the traditional
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plant treatments for diabetes have been
shifted scientific scrutiny, and the
World Health Organisation has
recommended that this area warrants
attention  (6).
Hemidesmus indicus (HI, Family –
Asclepiadaceae) known as Nannari in
Tamil, and Indian sarsaparilla in
English has been extensively used in
Ayurvedic system of medicine. Each
part of the plant has medicinal value.
The root gives cooling effect and used
in fever, diabetes, cough, cures blood
disorders, and has got diuretic effect (7,
8). This study was thus initiated with the
aim of evaluating the effects of an
aqueous extract of Hemidesmus indicus.
L. on the blood glucose level and serum
lipids in alloxan induced diabetic rats.
Materials and Methods :
Plant material :
Hemidesmus indicus L. roots were
collected from Maruthamalai hills,
Coimbatore District, Tamil nadu, India.
The plant was identified and
authenticated at the Department of
Botany, Kongu nadu Arts and Science
College, Coimbatore. 500g of the plant
was soaked overnight in 1.5 litres of
95% ethanol. This suspension was
filtered and the residue was
resuspended in an equal volume of 95%
ethanol for 48 h and filtered again. The
two filtrates were pooled and the
solvents were evaporated at 40° - 50° c
under reduced pressure and
lyophilized (9).
Animals :
All the experiments were carried out
with male Wister rats aged seven to
eight weeks (180 – 200g), obtained
from the Veterinary Hospital, Thrissur,
Kerala, India. The animals were housed
in polypropylene cages and provided
with water and standard pellet diet
(Karnataka Agro Food Corporation
Limited, Bangalore, India) ad Libitum.
The animals used in the present study
were approved by the ethical
committee. The care of the animals was
as per the “Guidelines for the care and
use of Animals in Scientific Research”
prepared by the Indian National
Science Academy, New Delhi (10).
Induction of experimental diabetes :
The rats were injected intraperitonially
with alloxan monohydrate dissolved in
sterile normal saline at a dose of 150
mg/kg body weight (11). After 2 weeks,
rats with moderate diabetes having
glycosuria (indicated by Benedict’s
qualitative test) and hyperglycemia (i.e.
with a blood glucose of 200 – 300 mg/
dl) were used for the experiment.
Experimental procedure :
In the experiment, a total of 25 rats (15
diabetic surviving rats, 10 normal rats)
were used. The rats were divided into
5 groups or five rats each.
Group 1 : Normal untreated rats.
Group 2 : Diabetic control rats given
1 ml of aqueous solution
HIR extract daily using
Intragastric tube for 30 days.
Group 3 : Diabetic rats given
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glibenclamide (600 ìg / kg
body weight) (12) in 1 ml of
aqueous solution daily
using an intragastric tube
for 30 days.
Group 4 : Diabetic rats given HIR
extract (400 mg/kg body
weight) in 1 ml of aqueous
solution  daily using an
intragastric tube for
30 days.
Group 5 : Normal rats given HIR
extract (400mg/kg body
weight) in 1 ml of aqueous
solution  daily using an
intragastric tube for
30 days.
At the end of 30 days, the animals were
deprived of food overnight and
sacrificed by decapitation. Blood was
collected in two different tubes that is
one with anticoagulant – potassium
oxalate and sodium fluoride for plasma
and another without anticoagulant for
serum separation. Plasma and serum
were separated by centrifugation.
Analytical procedure :
Blood glucose was estimated
by O – Toluidine method (Sasaki et
al)(1972)  (13). Lipids were extracted
from serum by the method of Folch et
al (1957) (14). Total cholesterol and
triglycerides were estimated by the
method of Zlatkis et al (1953) (15)
and Foster and Dunn (1973) (16)..
Free fatty acid and phospholipids were
analyzed by the method of Falholt et al
(1973) (17) and Zilversmit et al (1950) (18).
Statistical analysis :
All values were expressed as the mean
± SD obtained from a number of
experiments (n). Data from all the tables
of normal animals, diabetic control
animals, reference drug treated and
HIR extract treated animals were
compared by ONE WAY ANOVA
followed by Duncan’s Multiple Range
Test (DMRT) (19)..
Results :
Blood Glucose :
Table 1. Blood glucose and urine sugar of normal and experimental rats
Groups 
Blood glucose 
(mg/dl) 
Plasma insulin  
(µ U/ ml) 
Urine sugar A 
Group I  104.64±3.90  9.84±0.65  Nil 
Group II  300.80±0.40a* 3.38±0.71a* +++ 
Group III  109.20±1.93b* 9.52±0.69b* TRACE 
Group IV  111.20±2.05c*,ens 9.18±0.71c*,ens Nil 
Group V  106.80±2.60dns 9.80±0.52dns Nil 
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Values are given as Mean ± SD (n = 5 rats).
Statistical comparison: a: Group I and II, b: Group II and III, c: Group II and IV
     d: Group I and V, e: Group III and IV
     * P < 0.05, ns – not significant.
A – Indicates 0.25% sugar and (+++) indicates more 1% sugar.
Table 2.
Changes in levels of Cholesterol, Free fatty acid, triglycerides and
phospholipids in serum of normal and experimental animals.
Groups  Cholesterol 
(mg/dl) 
Free fatty acid 
(mg/dl) 
Triglycerides 
(mg/dl) 
Phospholipids 
(mg/dl) 
Group I  75.25±0.91  59.73±0.68  99.64±0.20  79.19±0.24 
Group II  174.20±0.58a* 119.90±1.54a* 167.54±1.14a* 132.80±1.49a* 
Group III  76.38±0.58b* 61.30±0.90b* 101.62±0.37b* 85.70±0.62b* 
Group IV  76.80±0.80c*,ens 61.38±0.13c*,ens 101.73±0.15c*,ens 85.79±0.25c*,ens 
Group V  75.68±0.91dns 60.69±0.84dns 99.69±0.07dns 79.86±0.66dns 
Values are given as Mean ± SD (n = 5 rats).
Statistical comparison :  a: Group I and II, b: Group II and III, c: Group II and IV
     d: Group I and V, e: Group III and IV
     * P < 0.05, ns – not significant.
Results :
Blood glucose :
Table 1 shows the levels of blood
glucose and urine sugar of normal and
experimental rats. There was a
significant elevation in blood glucose
in alloxan diabetic rats which
decreased significantly to normal level
in experimental rats when compared
with normal rats. Administration of
HIR extract and glibenclamide
separately tends to bring the
parameters significantly towards the
normal.
In diabetic rats the urine sugar was
(+++) but in the case of HIR extract
treated rats showed no urine sugar as
seen in normal rats. These effects were
compared with glibenclamide.
Serum lipids :
The effect of HIR extract on serum
lipids of normal and experimental rats
is summarized in Table 2. A marked
increase in the level of cholesterol, free
fatty acids, triglycerides and
phospholipids were observed in
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diabetic rats. Treatment with HIR extract
significantly reduced the lipid levels.
Discussion :
Alloxan is well known for its selective
pancreatic islet â – cell toxicity and has
been extensively used to induce
diabetes mellitus in animals. It
interferes with cellular metabolic
oxidative mechanisms (20). Intra
peritonial administration of alloxan
(150mg/kg) effectively induced
diabetes in normal rats as reflected by
glycosuria, hyperglycaemia, poly
phagia and polydipsia when
compared with normal rats (21). In our
present study we have observed that
an aqueous extract of Hemidesmus
indicus root can reverse these effects.
The possible mechanism by which HIR
extract brings about its antihy
perglycemic action may be by
potentiation of pancreatic secretion of
insulin from â – cell of islets or due to
enhanced transport of blood glucose
to peripheral tissue. This was clearly
evidenced by the increased level of
insulin in diabetic rats treated with
HIR extract. In this context a number
of other plants have also been reported
to have antihyperglycemic and insulin
– release stimulatory effect (22,23) .
Hypercholesterolemia and hypertriacy
lglycerolemia are major risk factors for
atherosclerosis and related occlusive
vascular disease (24). Clinical
complications such as atherosclerosis
could be diminished and life prolonged
when blood lipids are lowered by
hypocholesterolaemic drugs. (25, 26).
Excess of fatty acids in serum produced
by the alloxan – induced diabetes
promotes conversion of excess fatty
acids into phospholipids and
cholesterol in liver. These two
substances along with excess
triglycerides formed at the same time
in liver may be discharged into blood
in the form of lipoproteins (27). The
abnormal high concentration of serum
lipids in the diabetic subject is, mainly
due to increase in the mobilization of
free fatty acids from the peripheral fat
depots, since insulin inhibits the
hormone sensitive lipase. Hyper
cholesterolemia and hypertrig-
lyceridemia have been reported to occur
in alloxan diabetic rats (28,29) and
significant increase observed in our
experiment was in accordance to these
studies. The marked hyperlipidaemia
that is characteristic of the diabetic
state may therefore, be regarded as a
consequence of the uninhibited actions
of lipolytic hormones on the fat depots
(30).
Activities of enzymes suggest that
enhanced lipid metabolism during
diabetes is shifted towards
carbohydrate metabolism and it
enhances the utilization of glucose at
the peripheral sites. One of the possible
actions of HIR extract may be due to its
inhibition of endogenous synthesis of
lipids.
Conclusion :
It can be concluded from the data that
HIR extract significantly reduces the
levels of serum lipids, which are
actively raised in alloxan diabetes rats.
HIR extract has beneficial effect on
plasma insulin. Moreover its
antihyperlipidemic effect could
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represent a protective mechanism against the development of atherosclerosis.
References :
1. Arky RA. Clinical correlates of metabolic derangements of diabetes mellitus in: Kozak
GP. (Ed), Complications of Diabetes mellitus, Saunders WB. Philadelphia, 1982;
16-20.
2. Seifter S, England S. Energy metabolism, In: Arias I, Popper H, Schacter D, et al
(Eds.). The liver: Biology and Pathobiology, Rauen Press, New York, 1982; 219 – 49.
3. Sochor M, BaquerNz, McLean P. Glucose over and under utilization in diabetes:
Comparative studies on the change in activities of enzymes of glucose metabolism in
rat kidney and liver. Mol. Physiol. 1985; 51-68.
4. Baquer N. Glucose over utilization and under utilization in diabetes and effects of
antidiabetic compounds. Ann Real Acad Farm 1998; 64:147-80
5. Swanston Flatt SK, Day C, Bailey CJ and Flatt RR. Traditional plant remedies for
diabetes. Studies in the normal and Streptozotocin diabetic mice. Diabetologia 1990;
33:462-4.
6. WHO Expert Committee on diabetes mellitus second report. Technical Report Series
646. World Health Organization. Geneva 1980; 61.
7. Role of Biotechnology in medicinal and aromatic plants: Volume XIII.
8. Deepak Acharya and Rai M.K. Traditional knowledge for curing various ailments
among Gonds and Bharias of Patalkot valley, M.P., India 1996 -2000.
9. Pandey VN, Rajagopalan SS, ChowdhorryDP: An effective ayurvedic hypoglycemic
formulation. J. Res. Ayur. Sid. 1995, 16: 1-14.
10. Anonymous, Guidelines for care and use of animals in scientific research, Revised
edition, Indian National Science Academy, New Delhi (2000).
11. Katsumata K, Karsumata y, Ozawa T and Katsumata K: Potentiating effects of
combined usage of three sulfonylurea drugs on the occurrence of alloxan diabetic
rats. Horm. Metab. Res. 1999, 25: 125-126.
12. Pari L and Uma Maheswari J. Antihyperglycemic activity of Musa Sapentium flower:
Effect on lipid peroxidation in alloxan diabetic rats Phytother Res 2000; 14:1-3.
13. Sasaki T, Rinsho Kagaku, Matzy S and Sonal A. Effect of acetic acid concentration on
he color reaction in the O- toluidine boric acid method for blood glucose estimation.
1972; 1: 346-53.
14. Folch J, Less M and Solane SGH. A simple method for isolation and purification of
total lipids from animal tissues. J. Biol. Chem. 1957; 26: 497-509.
15. Zlatkis A, Zak B and Bogle GJ. A method for the determination of serum cholesterol
J Clin Med 1953; 41:486-92.
Pages 4 - 1010
16. Foster LB, Dunn RT. Stable reagents for determination of serum triglycerides by
colorimetric hantzsch condensation method. Clin. Chem. 1973; 19: 338-40.
17. Folholt K, Falholt W and Lund B. An easy colorimetric method for routine
determination of free fatty acids in plasma. Chem. Acta. 1973; 46: 105-11.
18. Zilversmit DB and Davis AK. Micro determination of phospholipids by TCA
precipitation. J. Lab. Clin. Med. 1950; 35: 155-61.
19. Bennet P and Franklin NH. Statistical analysis in chemistry and chemical industry.
New York: John Wiley and Sons, USA. 208-27.
20. Papaccio G, Pisanti FA, Latronico MV, Ammendola E and Galdieri M. Multiple low
dose and single high dose treatments with streptozotocin do not generate nitric oxide
J. Cell Biochem 2000; 77 (1) : 82-91.
21. Calabresi P and Chabner BA. Antineoplastic agents. In Goodman A, Rall JW (Eds).
The pharmacological basis of therapeutics. 8th Edition Pergmann Press, New York.
1209-63.
22. Prince PSM, Menon VP and Pari L Hypoglycemic activity of Syzigium cumini seeds:
Effect on lipid peroxidation in Alloxan diabetic rats. J. Ethanopharmcol 1998;61:1-7.
23. Pari L and Uma Maheswari J. hypoglycemic effect of Musa sapreitum L. in Alloxan
induced diabetic rats. J. Ethanopharmacal 1999;
24. Castelli W P, Garison R J, Wilson P W F, Abbot R D, Kalousdian S and Kaund W B,
Incidence of coronary artery disease and lipoprotein cholesterol levels, J. Am. Med.
Assoc. 256 (1986) 2835.
25. Lipid Research Clinics Program, The lipids research clinics coronary primary
prevention trial results. 1. Reduction in incidence of coronary heart disease, J.Am.
Med. Assoc. 251 (1984a) 251.
26. Lipid Research Clinical Program, The lipid research clinics coronary primary
prevention trial results. 11. The relationship of reduction in incidence of coronary
heart disease to cholesterol lowering, J. Am. Med. Assoc. 251 (1984b) 365.
27. Bopanna KN, Kannan J, Sushma G, Balaraman R, Rathod SP. Antidiabetic and
antihyperlipaemic effects of neem seed kernel powder on alloxan diabetic rabbits.
Indian J .Pharmacol 1997; 29: 162-7.
28. Sharma SR, Dwivedi SK and Swarup D. Hypoglycemic and hypolipidaemic effects
of Cinnamomum tomala nees leaves. Ind.J. Exp. Biol.1996; 34: 372-4.
29. Pushparaj P, Tan CH and Tan BKH. Effects of Averrhoa bilimli leaf extract on blood glucose
and lipids in Streptozotocin diabetic rats. J. Ethanopharmacol 2000; 72: 69-  76.
30. Goodman LS and  Gilman A. The pharmacological basis of therapeutics, 7th Edition.
Mac Millan, New York, 1985; 1490-510.
Pages 4 - 10